Showing results (1041-1050 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|May 4, 2016
Relative bioavailability of pediatric oral solution and tablet formulations of trametinib in adult patients with solid tumorsDonna S Cox, Alicia Allred, YanYan Zhou, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Effect of food on the bioavailability and tolerability of the JAK2-selective inhibitor fedratinib (SAR302503): Results from two phase I studies in healthy volunteersMeng Zhang, Christine Xu, Lei Ma, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairmentMohamed A Kamal, Barbara J Brennan, Vishak Subramoney, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Inhibition of prostacyclin and thromboxane biosynthesis in healthy volunteers by single and multiple doses of acetaminophen and indomethacinJules I Schwartz, Bret J Musser, Wesley K Tanaka, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Evaluation of the effect of multiple doses of rifampin on the pharmacokinetics and safety of ponatinib in healthy subjectsNarayana I Narasimhan, David J Dorer, Jeffrey Davis, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
The expanding utility of microdosingGraham Lappin
Clinical Pharmacology in Drug Development|May 4, 2016
Effect of tamsulosin on the pharmacokinetics of dutasteride in Chinese male healthy volunteersHuafang Li, Jiansong Yang, Hongxin Zhao, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Evaluation of opicapone on cardiac repolarization in a thorough QT/QTc studyRoberto Pinto, Philippe l'Hostis, Alain Patat, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin 5 monoclonal antibody, in healthy Japanese male subjectsNaohiro Tsukamoto, Naoki Takahashi, Hiroshi Itoh, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
The relative bioavailability of 2 prototype fixed-dose combination formulations for amlodipine and rosuvastatin in healthy white and Chinese subjectsHtar H Nwe, Jonathan N Bullman, Shashidhar M Joshi, et al.
Pageof 136